Enanta Pharmaceuticals
ENTA
#8066
Rank
NZ$0.65 B
Marketcap
NZ$22.64
Share price
3.66%
Change (1 day)
63.40%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -NZ$87.57 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$69.21 Million. In 2025 the company made an earning of -NZ$0.11 Billion, an increase over its 2024 earnings that were of -NZ$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$87.57 Million-19.55%
2025 -NZ$0.11 Billion-34.07%
2024 -NZ$0.17 Billion-23.87%
2023 -NZ$0.22 Billion4.39%
2022 -NZ$0.21 Billion-4.4%
2021 -NZ$0.22 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$37.02 M-78.63%
2018 NZ$0.17 B117.97%
2017 NZ$79.48 M-574.65%
2016 -NZ$16.75 Million-110.83%
2015 NZ$0.15 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$30.08 Million-137.98%
2012 NZ$79.17 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.21 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.86 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$10.16 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.61 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.38 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.33 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA